Companies / Abbott Laboratories
Abbott Laboratories
ABT United States
ID 39 · CIK 1800 · reconciled 2026-10-10T16:40
SEC EDGAR filings ↗ Raw model extractions
Employees (legacy)
Revenue FY2025
44.3B
▲ 5.7% vs FY2024
Net profit FY2025
6.5B
▼ 51.3% vs FY2024
Total assets FY2025
86.7B
▲ 6.5% vs FY2024
Stockholders' equity FY2025
52.1B
▲ 9.4% vs FY2024
Operating cash flow FY2025
9.6B
▲ 11.8% vs FY2024
EPS (diluted) FY2025
3.72
▼ 51.3% vs FY2024
Employees FY2025
115,000
▲ 0.9% vs FY2024
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
reported (validated by 2+ models)calculated (Q4 = FY − Q3 YTD, YTD differences)discarded (models did not agree)
Hover a cell for the vote details. Amounts in millions, EPS per share, headcount as-is.
All entities
Segment data comes from F4: entity names are clustered across models with Qwen, then each period is a majority vote.
Unlike F1–F3 there is no 2-model minimum — hover a value to see how many models reported it.
Vote results
| Source | Validated | Discarded | Calculated | Empty | Discard rate |
|---|---|---|---|---|---|
| F1 · income statement | 1,600 | 103 | 362 | 306 | 6.0% |
| F2 · balance sheet | 2,515 | 157 | 0 | 1,048 | 5.9% |
| F3 · cash flow | 523 | 37 | 760 | 246 | 6.6% |
| F5 · human capital | 60 | 2 | 0 | 403 | 3.2% |
Re-run plan for this company
| Action | Source | Form | Period end | Accession | Tier | Fields | Missing models |
|---|---|---|---|---|---|---|---|
| third ai optional | F1 | 10-Q | 2001-09-30 | 0000912057-01-537337 | 4 | shares_outstanding | no-ai-xblr |
| third ai optional | F1 | 10-Q | 2002-03-31 | 0000912057-02-018154 | 4 | shares_outstanding | no-ai-xblr |
| third ai optional | F1 | 10-Q | 2002-06-30 | 0000912057-02-031585 | 4 | shares_outstanding | no-ai-xblr |
| third ai optional | F1 | 10-Q | 1995-09-30 | 0000912057-95-009918 | 4 | eps_basic[3mo] | no-ai-xblr |
| run third ai | F1 | 10-Q | 1996-06-30 | 0000912057-96-017491 | 3 | eps_diluted[ytd] | no-ai-xblr |
| third ai optional | F1 | 10-Q | 2003-03-31 | 0001047469-03-018718 | 4 | shares_outstanding | no-ai-xblr |
| third ai optional | F1 | 10-Q | 2003-06-30 | 0001047469-03-027213 | 4 | shares_outstanding | no-ai-xblr |
| third ai optional | F1 | 10-Q | 2003-09-30 | 0001047469-03-036636 | 4 | shares_outstanding | no-ai-xblr |
| third ai optional | F1 | 10-Q | 2008-03-31 | 0001104659-08-029545 | 4 | shares_outstanding | no-ai-xblr |
| third ai optional | F1 | 10-Q | 2008-06-30 | 0001104659-08-047788 | 4 | shares_outstanding | no-ai-xblr |
| skip | F2 | 10-K405 | 1999-12-31 | 0000912057-00-011377 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-K | 2013-12-31 | 0001047469-14-001176 | total_liabilities | ||
| skip | F2 | 10-K | 2018-12-31 | 0001047469-19-000624 | total_liabilities | ||
| skip | F2 | 10-K | 1997-12-31 | 0001047469-98-009108 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-K | 2022-12-31 | 0001628280-23-004026 | total_liabilities | ||
| skip | F2 | 10-K | 2023-12-31 | 0001628280-24-005348 | total_liabilities | ||
| skip | F2 | 10-K | 2024-12-31 | 0001628280-25-007110 | total_liabilities | ||
| skip | F2 | 10-K | 2025-12-31 | 0001628280-26-010185 | total_liabilities | ||
| skip | F2 | 10-Q | 2005-09-30 | 0001104659-05-051849 | total_liabilities | no-ai-xblr | |
| skip | F2 | 10-Q | 2011-03-31 | 0001104659-11-026773 | total_liabilities | ||
| skip | F2 | 10-Q | 2011-06-30 | 0001104659-11-043664 | total_liabilities | ||
| skip | F2 | 10-Q | 2011-09-30 | 0001104659-11-061064 | total_liabilities | ||
| skip | F2 | 10-Q | 2012-06-30 | 0001104659-12-055154 | total_liabilities | ||
| skip | F2 | 10-Q | 2012-09-30 | 0001104659-12-075249 | total_liabilities | ||
| skip | F2 | 10-Q | 2014-03-31 | 0001104659-14-035832 | total_liabilities | ||
| skip | F2 | 10-Q | 2014-06-30 | 0001104659-14-056950 | total_liabilities | ||
| skip | F2 | 10-Q | 2015-03-31 | 0001104659-15-034919 | total_liabilities | ||
| skip | F2 | 10-Q | 2015-06-30 | 0001104659-15-055905 | total_liabilities | ||
| skip | F2 | 10-Q | 2015-09-30 | 0001104659-15-076189 | total_liabilities | ||
| skip | F2 | 10-Q | 2016-03-31 | 0001104659-16-117710 | total_liabilities | ||
| skip | F2 | 10-Q | 2016-06-30 | 0001104659-16-136572 | total_liabilities | ||
| skip | F2 | 10-Q | 2016-09-30 | 0001104659-16-154583 | total_liabilities | ||
| skip | F2 | 10-Q | 2018-06-30 | 0001104659-18-048736 | total_liabilities | ||
| skip | F2 | 10-Q | 2018-09-30 | 0001104659-18-065076 | total_liabilities | ||
| skip | F2 | 10-Q | 2019-03-31 | 0001104659-19-026018 | total_liabilities | ||
| skip | F2 | 10-Q | 2019-09-30 | 0001104659-19-058323 | total_liabilities | ||
| skip | F2 | 10-Q | 2020-03-31 | 0001104659-20-053384 | total_liabilities | ||
| skip | F2 | 10-Q | 2020-06-30 | 0001104659-20-087850 | total_liabilities | ||
| skip | F2 | 10-Q | 2020-09-30 | 0001104659-20-121336 | total_liabilities | ||
| skip | F2 | 10-Q | 2021-06-30 | 0001104659-21-100055 | total_liabilities | ||
| skip | F2 | 10-Q | 2022-03-31 | 0001104659-22-055285 | total_liabilities | ||
| skip | F2 | 10-Q | 2019-06-30 | 0001410578-19-000606 | total_liabilities | ||
| skip | F2 | 10-Q | 2022-06-30 | 0001628280-22-020209 | total_liabilities | ||
| skip | F2 | 10-Q | 2022-09-30 | 0001628280-22-027550 | total_liabilities | ||
| skip | F2 | 10-Q | 2023-03-31 | 0001628280-23-015699 | total_liabilities | ||
| skip | F2 | 10-Q | 2023-06-30 | 0001628280-23-027203 | total_liabilities | ||
| skip | F2 | 10-Q | 2023-09-30 | 0001628280-23-035957 | total_liabilities | ||
| skip | F2 | 10-Q | 2024-03-31 | 0001628280-24-020011 | total_liabilities | ||
| skip | F2 | 10-Q | 2024-06-30 | 0001628280-24-033740 | total_liabilities | ||
| skip | F2 | 10-Q | 2024-09-30 | 0001628280-24-044602 | total_liabilities | ||
| skip | F2 | 10-Q | 2025-03-31 | 0001628280-25-021090 | total_liabilities | ||
| skip | F2 | 10-Q | 2025-06-30 | 0001628280-25-036720 | total_liabilities | ||
| skip | F2 | 10-Q | 2025-09-30 | 0001628280-25-047131 | total_liabilities | ||
| skip | F2 | 10-Q | 2026-03-31 | 0001628280-26-028357 | total_liabilities | ||
| skip | F2 | 10-Q | 2026-06-30 | 0001628280-26-050134 | total_liabilities | ||
| third ai optional | F3 | 10-Q | 2000-06-30 | 0000912057-00-034504 | 4 | capital_expenditure[ytd] | no-ai-xblr |
| run third ai | F5 | 10-K | 2016-12-31 | 0001047469-17-000744 | 2 | employees_total |